AltPep Corp offers a groundbreaking peptide-based platform that detects and neutralizes toxic precursors to amyloid diseases. Their innovative approach encompasses diagnostic, therapeutic, and anti-biofilm applications, with a specific focus on early detection of toxic oligomers in Alzheimer's disease through a soluble oligomer binding assay. By providing healthcare institutions with the means to identify and treat amyloid diseases at an early stage, AltPep aims to improve human health and combat these challenging conditions.